Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Laura, Liao"'
Autor:
Mehdi, Hamadani, Lei, Chen, Yan, Song, Michael K, Xu, Laura, Liao, Paolo F, Caimi, Carmelo, Carlo-Stella
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e738-e744
Loncastuximab tesirine (Lonca) and chemoimmunotherapy (CIT) have been assessed in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL), but direct evidence from head-to-head randomized clinical trials is not available.Matching-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a72fe66d263061e2e8d283f4d94ef602
https://doi.org/10.1016/j.clml.2022.04.006
https://doi.org/10.1016/j.clml.2022.04.006
Publikováno v:
Blood. 140:8058-8060
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d365d51711378eeacd927443af4f738
https://doi.org/10.1182/blood-2022-167753
https://doi.org/10.1182/blood-2022-167753
Autor:
Dai Chihara, Laura Liao, Joseph Tkacz, Benjamin Lewing, Anjali Franco, Karl M. Kilgore, Loretta J. Nastoupil, Lei Chen
Publikováno v:
Blood. 140:2421-2423
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75fc7f4effd22c2b2eb295d100775d6b
https://doi.org/10.1182/blood-2022-163678
https://doi.org/10.1182/blood-2022-163678
Autor:
Alexander Spira, Laura Liao, Xiaolei Zhou, Bintu Sherif, Lei Chen, David Ungar, Eric Yu, John Radford, Mehdi Hamadani
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75bac87bc6f1ba9114f203a0d233525c
https://doi.org/10.6004/jnccn.2021.7242
https://doi.org/10.6004/jnccn.2021.7242
Autor:
Laura Liao, Brad S. Kahl, John Radford, Xiaolei Zhou, David Ungar, Ari Gnanasakthy, Rafael E. Curiel, Luqiang Wang, Lei Chen, Alexander I. Spira
Publikováno v:
Spira, A, Zhou, X, Chen, L, Gnanasakthy, A, Wang, L, Ungar, D, Curiel, R, Liao, L, Radford, J & Kahl, B 2021, ' Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma ', Clinical Lymphoma, Myeloma and Leukemia . https://doi.org/10.1016/j.clml.2021.09.001
Background Loncastuximab tesirine has shown antitumor activity with an acceptable toxicity profile in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who were relapsed or refractory after ≥2 prior therapies, including act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6180cbd7257cb70367a8590cb2412e
https://doi.org/10.1016/j.clml.2021.09.001
https://doi.org/10.1016/j.clml.2021.09.001
Autor:
Laura Liao
In this work, two studies were performed where mathematical models (MM) were used to re-examine and refine quantitative methods based on in vitro assays of influenza A virus infections. In the first study, we investigated the standard experimental me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80318ff443abb4eddf9ebc6eab5c50bc
https://doi.org/10.32920/ryerson.14663724
https://doi.org/10.32920/ryerson.14663724
Autor:
Alexander Spira, Xiaolei Zhou, Laura Liao, Eric Yu, Lei Chen, Augustine Lau, Ying Wang, Ari Gnanasakthy, John Radford, Mehdi Hamadani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S371-S372
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b7aa0064df22f917142e0dd368d0cb8
https://doi.org/10.1016/s2152-2650(22)01526-9
https://doi.org/10.1016/s2152-2650(22)01526-9
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(6)
Introduction The treatment landscape for diffuse large B-cell lymphoma (DLBCL) has recently changed. We examined characteristics and clinical outcomes of DLBCL patients who initiated a third (3L) and fourth (4L) line of therapy during a contemporary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe90db076e43695c9b37c18b6ffad51
https://pubmed.ncbi.nlm.nih.gov/34933826
https://pubmed.ncbi.nlm.nih.gov/34933826
Autor:
Mehdi Hamadani, Christopher Graham, Laura Liao, Kate Zhang, Hannah Strat, David Ungar, Weiyun Ai, Lei Chen, Carmelo Carlo-Stella
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::936e1d06d73f0f882cf7ccebfb0d2b46
https://doi.org/10.1016/s2152-2650(22)01003-5
https://doi.org/10.1016/s2152-2650(22)01003-5
Autor:
Mehdi Hamadani, Christopher Graham, Laura Liao, Kate Zhang, Hannah Strat, David Ungar, Weiyun Ai, Lei Chen, Carmelo Carlo-Stella
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64e641f874bf9da6cd460db5d6b45b9d
https://doi.org/10.1016/s2152-2650(22)01529-4
https://doi.org/10.1016/s2152-2650(22)01529-4